Sioux Falls, SD — The company that runs the hospitals in Sheldon, Orange City, Rock Rapids, and several other northwest Iowa towns has announced the purchase of a Sioux Falls biotech research company.
Sanford Health, based in Sioux Falls and Fargo has acquired Sioux Falls-based biotech company Hematech, Inc., a subsidiary of a Japanese pharmaceutical company. The new company will be re-branded Sanford Applied Biosciences, LLC.
Dave Link, senior executive vice president of Sanford Health says that they are excited about the expertise Hematech researchers bring to Sanford Research. He says that for more than a decade, Hematech has been conducting cutting-edge research in Sioux Falls. By coming together, Link says they believe they can build on Hematech’s expertise and technology and bring about new solutions to serious health issues.
In 2003, Hematech formed a joint venture with Trans Ova Genetics of Sioux Center. Trans Ova is one of the world’s largest bovine embryo transfer companies. The Hematech/Trans Ova Joint Venture was formed to manage all of Hematech’s animal needs, including work at the Research Development Center located near Sioux Center. As part of the acquisition, Trans Ova will continue that work for Sanford Applied Biosciences, LLC.